Invasive Pneumococcal Disease and 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Coverage Among Children Aged ≤59 Months -- Selected U.S. Regions, 2010-2011

Harriman, Kathleen; Thomas, Tracy N.; Cullen, Karen; Pabst, Laura; Shefer, Abigail; Link-Gelles, Ruth; Kolasa, Maureen; Cox, Chad; Moore, Matthew
November 2011
MMWR: Morbidity & Mortality Weekly Report;11/4/2011, Vol. 60 Issue 43, p1477
The article focuses on recommendations published by Advisory Committee on Immunization Practices (ACIP) for use of a newly licensed, 13-valent pneumococcal conjugate vaccine (PCV13) for Invasive Pneumococcal Disease. The vaccine is meant for all children aged 14 through 59 months. It informs on what PCV13 consists of including when, how far and for what type it must be administered. Statistics are provided on number of IPD cases caused by serotypes unique to PCV13.


Related Articles

  • Economic evaluation of a pneumococcal vaccine in a high-risk population. Agarwal, Sushil // Thorax;Nov2013, Vol. 68 Issue 11, p1065 

    In this article, the author focuses on an economic evaluation study related to the cost effectiveness of a 13-valent pneumococcal conjugate vaccine used for invasive pneumococcal disease in a population presented with high risk of the disease. According to the study, the incremental...

  • Incidence of pediatric invasive pneumococcal disease in the Island of Majorca (2008-2010), an area with non-universal vaccination, and estimations of serotype & children population coverage by available conjugate vaccines. Picazo, Juan; Dueñas, Joaquin; Ramirez, Antonio; Perez, Andres-Ricardo; Padilla, Emma; Herrero, Susana; Gallegos, Carmen; Culebras, Esther; Balseiro, Cesar; Mendez, Cristina // BMC Infectious Diseases;2013, Vol. 13 Issue 1, p1 

    Background The World Health Organization reported in 2007 that inclusion of PCV7 in national immunization programs should be seen as a priority, also encouraging countries to conduct appropriate surveillances for monitoring the impact of vaccination. These analyses should be conducted in...

  • Racial Disparities in Invasive Streptococcus pneumoniae Infections, 1998–2009. Wortham, Jonathan M.; Zell, Elizabeth R.; Pondo, Tracy; Harrison, Lee H.; Schaffner, William; Lynfield, Ruth; Thomas, Ann; Reingold, Arthur; Bennett, Nancy M.; Petit, Susan; Aragon, Deborah; Bareta, Joseph; Juni, Billie A.; Farley, Monica M.; Beall, Bernard; Moore, Matthew R. // Clinical Infectious Diseases;May2014, Vol. 58 Issue 9, p1250 

    Introduction of 7-valent pneumococcal conjugate vaccine (PCV7) resulted in elimination of racial disparities in PCV7-type invasive pneumococcal disease (IPD) rates. New conjugate vaccines and strategies to address underlying etiologies behind racial disparities are needed to eliminate...

  • Pneumococcal Vaccine: The Evidence Mounts. LaForce, Marc // Annals of Internal Medicine;Jan86, Vol. 104 Issue 1, p110 

    Editorial. Explores the efficacy of pneumococcal pneumonia vaccine in the U.S. Results of field trials; Approach in measuring vaccine efficacy; Recommendations on the use of pneumococcal vaccine.

  • Pneumonia Vaccine--Don't Leave Home Without It. Brown, Edwin W. // Medical Update;Mar99, Vol. 22 Issue 9, p4 

    Focuses on pneumonia vaccine in the United States. Types of people eligible for the vaccine; Reasons for people's reluctance to be vaccinated.

  • Flag charts to assure vaccination against pneumococcal pneumonia.  // Geriatrics;Nov97, Vol. 52 Issue 11, p17 

    Focuses on flagging patient's chart to assure vaccination against pneuomococcal pneumonia. Recommendations of Chatrchai Watanakunakorn, director of infectious disease at Saint Elizabeth Health Center in Youngstown, Ohio about pneumococcal vaccine; Results of Watanakunakorn's study on patients...

  • PCV7 may have reduced pneumococcal infections among White Mountain Apache population. Volansky, Rob // Infectious Diseases in Children;Sep2008, Vol. 21 Issue 9, p26 

    The article discusses research being done on pneumococcal infections. It references a study by R. Lacapa et al, published in a 2008 issue of "Clinical Infectious Diseases." Study findings revealed that the incidence of pneumococcal infections among White Mountain Apache children has declined...

  • Routine pneumococcal vaccination reasonably cost effective in Spain.  // PharmacoEconomics & Outcomes News;3/26/2005, Issue 474, p9 

    Discusses research being done on the cost effectiveness of routine pneumococcal vaccination in Spain. Reference to a study by E. Navas et al, published in the March 18, 2005 issue of the "Vaccine" journal; Effectiveness of routine vaccination in preventing cases of invasive pneumococcal disease...

  • Older adults are still not receiving pneumococcal vaccine.  // Modern Medicine;Jul95, Vol. 63 Issue 7, p35 

    Reports on the low vaccination rates for pneumococcal pneumonia due to incomplete vaccination of older adults in the United States based on a survey by Mark A. Miller presented at the International Conference of the American Lung Association and American Thoracic Society on May 20-24, 1995. ...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics